FMC
11/12/26

FMC (FMC)

Thursday
10:21 AM
ThesisFMC: the risks are mounting — Generic competition intensification - Chinese and Indian manufacturers expanding capacity for off-patent active…

Revenue Outlook

★ Analysts see FY2027 revenue reaching $3.4B — +20.8% growth in a single year.

What Could Go Wrong

  1. 01Generic competition intensification - Chinese and Indian manufacturers expanding capacity for off-patent active ingredients, compressing pricing power on mature products
  2. 02Regulatory restrictions on key chemistries - neonicotinoid bans in Europe, glyphosate litigation and restrictions, environmental regulations limiting product portfolios
  3. 03Climate change and pest resistance - changing weather patterns affect pest pressure, while overuse drives resistance requiring new chemistry development
  4. 04Consolidation among agricultural retailers and cooperatives - increases buyer power and pricing pressure on suppliers
  5. 05Market share loss to larger competitors (Bayer, BASF, Corteva, Syngenta) with broader portfolios and stronger balance sheets during downturn
  6. 06Biological and precision agriculture alternatives - biopesticides, gene editing, and digital farming tools potentially displacing traditional chemicals
  7. 07Vertical integration by seed companies - major players bundling crop protection with seeds and traits
  8. 08Liquidity crisis risk - negative $100M operating cash flow with 1.94x debt/equity requires asset sales, equity raise, or debt restructuring if conditions persist
FY2025 Snapshot
Revenue
$3.5B
EPS
$-17.88
1Y Return
-58.8%

FMC Chart

3.96.69.312.014.75.65FMC Daily5.65Jun '26Aug '26Sep '26Nov '26

My Notes

  • value/distressed - The 0.5x price/sales, 0.9x price/book, and -62% one-year return attract deep value investors betting on cyclical recovery…
  • Rising interest rates negatively impact FMC through multiple channels: (1) higher financing costs on $3.5B+ debt burden with 1.94x…
  • Watch on earnings: Corn futures (ZCUSX) and soybean futures (ZSUSX) - primary driver of North American farmer economics and input spending, Brazilian real exchange rate - critical for largest growth market revenue translation and local pricing power, Crude oil prices (CLUSD) - proxy for petrochemical feedstock costs affecting gross margins.

One Sentence Summary:

The bear case: generic competition intensification - chinese and indian manufacturers expanding capacity for off-patent active ingredients.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.